Re-presentation of segment results and changes in terminology
Small320px x 240px
Medium840px x 630px
Large1440px x 1024px
The Medibank Group plans to announce its 2026 half year financial results on 19 February 2026.
To assist investors ahead of the release of the 2026 half year financial results, additional detail is provided for the Medibank Health operating segment for the 2025 financial year, along with two changes in terminology.
Re-presentation of Medibank Health results
This additional information for Medibank Health follows the Health Immersion held on 29 October 2025, where Medibank provided further detail on Medibank Health performance across the wellbeing, primary care, and community and acute businesses.
There have been no changes to the previously reported statutory financial results and the Medibank Group’s previously issued financial statements have not been restated.
To support comparability and reflect the way Medibank Health performance is managed and reviewed, historical Medibank Health information for the year ended 30 June 2025 and the half year ended 31 December 2024 has been re-presented. This aligns with the updated Medibank Health reporting structure, which will be applied on a go forward basis.
In addition, the allocation of certain costs between gross margin and operating expenses within primary care has been reviewed and updated to align with this presentation and with the recently acquired Better Medical business.
Attachment 1 contains a summary of the changes.
The information in Attachment 2 is provided to assist investors during the transition to the updated presentation of Medibank Health information and comprises:
Re-presented Medibank Health results for the half year ended 31 December 2024 (1H25)
Re-presented Medibank Health results for the financial year ended 30 June 2025 (FY25)
Changes in terminology
From 1H26, Medibank will replace the term “downgrading” with “revenue mix”. The underlying calculation is unchanged and continues to reflect the difference between the average premium rate rise and reported revenue growth per policy unit in the resident private health insurance segment.
The updated terminology better reflects the drivers of this measure which includes customer policy changes (including upgrading and downgrading cover, adding and removing ancillary services and changing excess levels), acquisition and lapse mix and other impacts (including investments in offers, discounts and other customer benefits).
The term “management expenses” will be replaced with the term “expenses” to reflect the broader nature of these expenses. The composition and calculation of these expenses are unchanged.
This announcement has been authorised for release by the Board.
For a complete list of all ASX announcements, please visit our Investor Centre.